MEI Pharma, Inc.

DB:MMI0 Stock Report

Market Cap: €44.1m

MEI Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MMI0?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,8590.0279%
Individual Insiders37,8150.568%
Hedge Funds1,023,61215.4%
Institutions1,938,65129.1%
General Public3,660,92054.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 44.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.94%
Anson Group
662,528€4.4m0%1.5%
5.76%
The Vanguard Group, Inc.
383,551€2.5m0%no data
5.42%
Tang Capital Management, LLC
361,084€2.4m39.9%0.34%
4.9%
Cable Car Capital, LLC
326,400€2.2m0%5.88%
3.57%
Acadian Asset Management LLC
237,918€1.6m0%no data
2.19%
Tavistock Life Sciences
145,654€965.1k0%0.05%
2.1%
Renaissance Technologies LLC
140,217€929.1k5.25%no data
1.93%
Laurion Capital Management LP
128,845€853.7k0%0.04%
1.58%
Carlson Capital, L.P.
105,000€695.7k78%0.07%
1.51%
TLS Advisors LLC
100,514€666.0k0%2.53%
1.1%
Morgan Stanley & Co. International Plc Investment Account
73,199€485.0k692%no data
1.01%
BlackRock, Inc.
67,510€447.3k-12.6%no data
0.72%
Geode Capital Management, LLC
47,835€317.0k0%no data
0.57%
Medical Strategy GmbH, Asset Management Arm
38,218€253.2k0%0.02%
0.45%
Macquarie Investment Management Business Trust
30,000€198.8k0%no data
0.31%
Daniel Gold
20,866€138.3k0%no data
0.27%
State Street Global Advisors, Inc.
17,822€118.1k0%no data
0.18%
Wells Fargo & Company, Securities and Brokerage Investments
11,749€77.9k-10.1%no data
0.18%
Two Sigma Investments, LP
11,696€77.5k26.9%no data
0.16%
Northern Trust Global Investments
10,577€70.1k-1.44%no data
0.11%
PGIM, Inc.
7,320€48.5k0%no data
0.11%
Granate Asset Management (Pty) Ltd
7,000€46.4k-30.2%0.19%
0.1%
Investmark Advisory Group LLC
6,800€45.1k0%0.03%
0.1%
Millennium Management LLC
6,738€44.6k-60.7%no data
0.1%
Jane Street Group, LLC, Asset Management Arm
6,685€44.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/07/16 06:38
End of Day Share Price 2023/04/18 00:00
Earnings2023/03/31
Annual Earnings2022/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MEI Pharma, Inc. is covered by 14 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephen V. ByrneBofA Global Research
Jonathan AschoffBrean Capital
Gene MackBrean Capital